查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991480

2026-2034年全球獸醫分子診斷市場規模、佔有率、趨勢和成長分析報告

Global Veterinary Molecular Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計獸醫分子診斷市場將從 2025 年的 20.6 億美元成長到 2034 年的 53.4 億美元，2026 年至 2034 年的複合年成長率為 11.14%。

隨著動物醫療保健和疾病檢測技術的進步，全球獸醫分子診斷市場也隨之成長。獸醫分子診斷利用聚合酵素鏈鎖反應(PCR) 和 DNA 分析等先進的實驗室技術來檢測動物感染疾病。這些方法能夠準確、快速地識別影響家畜和伴侶動物的病原體。

推動該市場成長的因素有很多。畜牧業對有效疾病監測的需求不斷成長，推動了先進診斷工具的應用。農民和獸醫依靠分子診斷技術來早期發現疾病並預防疫情爆發。此外，寵物數量的增加也提高了動物醫院對先進診斷服務的需求。

隨著動物健康管理日趨完善，獸醫分子診斷市場前景依然光明。基因檢測和攜帶式診斷技術的進步有望提升疾病檢測和監測能力。獸醫和畜牧管理領域投資的增加預計將推動市場擴張。隨著動物健康重要性的不斷提升，對分子診斷技術的需求也預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球獸醫分子診斷市場：依產品分類

  • 市場分析、洞察與預測
  • 裝置
  • 檢測套組和試劑
  • 軟體服務

第5章：全球獸醫分子診斷市場：依動物種類分類

  • 市場分析、洞察與預測
  • 伴侶動物
  • 生產動物

第6章：全球獸醫分子診斷市場：依技術分類

  • 市場分析、洞察與預測
  • PCR
  • DNA定序
  • 微陣列
  • INAAT套件

第7章：全球獸醫分子診斷市場：依應用分類

  • 市場分析、洞察與預測
  • 感染疾病
  • 代謝性疾病
  • 遺傳學
  • 其他用途

第8章：全球獸醫分子診斷市場：依最終用途分類

  • 市場分析、洞察與預測
  • 獸醫醫院和診所
  • 診斷檢查室
  • 其他最終用途

第9章：全球獸醫分子診斷市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zoetis
    • IDEXX
    • Antech Diagnostics Inc.（Mars Inc.）
    • Thermo Fisher Scientific Inc
    • Neogen Corporation
    • Gold Standard Diagnostics（Eurofins Technologies）
    • Bio-Rad Laboratories Inc
    • Ring Biotechnology Co Ltd
    • QIAGEN NV
    • BIONOTE
簡介目錄
Product Code: VMR11214150

The Veterinary Molecular Diagnostics Market size is expected to reach USD 5.34 Billion in 2034 from USD 2.06 Billion (2025) growing at a CAGR of 11.14% during 2026-2034.

The global veterinary molecular diagnostics market has grown as animal healthcare and disease detection technologies continue to advance. Veterinary molecular diagnostics involve the use of advanced laboratory techniques such as polymerase chain reaction and DNA analysis to detect infectious diseases in animals. These methods provide accurate and rapid identification of pathogens affecting livestock and companion animals.

Several factors are driving the growth of this market. The increasing demand for effective disease monitoring in livestock production has encouraged the use of advanced diagnostic tools. Farmers and veterinarians rely on molecular diagnostics to detect diseases early and prevent outbreaks. In addition, rising pet ownership has increased the need for advanced diagnostic services in veterinary clinics.

The future outlook for the veterinary molecular diagnostics market remains promising as animal health management becomes more sophisticated. Advances in genetic testing and portable diagnostic technologies may improve disease detection and monitoring capabilities. Increasing investments in veterinary healthcare and livestock management are expected to support market expansion. As the importance of animal health continues to grow, demand for molecular diagnostic technologies will likely increase.

MARKET SEGMENTATION

By Product

  • Instruments
  • Test Kits & Reagents
  • Software & Services

By Animal Type Outlook

  • Companion Animal
  • Production Animals

By Technology

  • PCR
  • DNA Sequencing
  • Microarrays
  • INAAT Kits

By Application

  • Infectious Diseases
  • Metabolic Disease
  • Genetics
  • Other Application

By End-use

  • Veterinary Hospitals & Clinics
  • Diagnostic Laboratories
  • Other End-use

COMPANIES PROFILED

  • Zoetis, IDEXX, Antech Diagnostics Inc Mars Inc, Thermo Fisher Scientific Inc, Neogen Corporation, Gold Standard Diagnostics Eurofins Technologies, BioRad Laboratories Inc, Ring Biotechnology Co Ltd, QIAGEN NV, BIONOTE
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Test Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY ANIMAL TYPE OUTLOOK 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Animal Type Outlook
  • 5.2. Companion Animal Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Production Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technology
  • 6.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. INAAT Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Metabolic Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Genetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Other Application Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Veterinary Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Other End-use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Animal Type Outlook
    • 9.2.3 By Technology
    • 9.2.4 By Application
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Animal Type Outlook
    • 9.3.3 By Technology
    • 9.3.4 By Application
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Animal Type Outlook
    • 9.4.3 By Technology
    • 9.4.4 By Application
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Animal Type Outlook
    • 9.5.3 By Technology
    • 9.5.4 By Application
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Animal Type Outlook
    • 9.6.3 By Technology
    • 9.6.4 By Application
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY MOLECULAR DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Zoetis
    • 11.2.2 IDEXX
    • 11.2.3 Antech Diagnostics Inc. (Mars Inc.)
    • 11.2.4 Thermo Fisher Scientific Inc
    • 11.2.5 Neogen Corporation
    • 11.2.6 Gold Standard Diagnostics (Eurofins Technologies)
    • 11.2.7 Bio-Rad Laboratories Inc
    • 11.2.8 Ring Biotechnology Co Ltd
    • 11.2.9 QIAGEN N.V
    • 11.2.10 BIONOTE